Company Overview of GenPharm International, L.L.C.
GenPharm International, L.L.C. develops and commercializes HuMAb-Mouse transgenic animal technology. Its technology is used in the creation of human monoclonal antibodies for therapeutic uses. The company was founded in 1989 and is based in San Jose, California. As of October 21, 1997, GenPharm International, L.L.C. operates as a subsidiary of Bristol-Myers Squibb Company.
2350 Qume Drive
San Jose, CA 95131
Founded in 1989
Key Executives for GenPharm International, L.L.C.
GenPharm International, L.L.C. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact GenPharm International, L.L.C., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.